Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 309

1.

Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects.

Dale PS, Tamhankar CP, George D, Daftary GV.

Cancer Chemother Pharmacol. 2001 Jul;47 Suppl:S29-34.

PMID:
11561869
2.

Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers.

Gujral MS, Patnaik PM, Kaul R, Parikh HK, Conradt C, Tamhankar CP, Daftary GV.

Cancer Chemother Pharmacol. 2001 Jul;47 Suppl:S23-8.

PMID:
11561868
3.

Influence of a complementary treatment with oral enzymes on patients with colorectal cancers--an epidemiological retrolective cohort study.

Popiela T, Kulig J, Hanisch J, Bock PR.

Cancer Chemother Pharmacol. 2001 Jul;47 Suppl:S55-63.

PMID:
11561874
4.

Impact of complementary oral enzyme application on the postoperative treatment results of breast cancer patients--results of an epidemiological multicentre retrolective cohort study.

Beuth J, Ost B, Pakdaman A, Rethfeldt E, Bock PR, Hanisch J, Schneider B.

Cancer Chemother Pharmacol. 2001 Jul;47 Suppl:S45-54.

PMID:
11561873
5.

Evaluation of morbidity after external radiotherapy and intracavitary brachytherapy in 771 patients with carcinoma of the uterine cervix or endometrium.

Yalman D, Arican A, Ozsaran Z, Celik OK, Yürüt V, Esassolak M, Haydaroglu A.

Eur J Gynaecol Oncol. 2002;23(1):58-62.

PMID:
11876395
6.

High dose-rate brachytherapy for elderly patients with uterine cervical cancer.

Chen SW, Liang JA, Yang SN, Lin FJ.

Jpn J Clin Oncol. 2003 May;33(5):221-8.

PMID:
12865465
7.

Unique role of proximal rectal dose in late rectal complications for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy.

Cheng JC, Peng LC, Chen YH, Huang DY, Wu JK, Jian JJ.

Int J Radiat Oncol Biol Phys. 2003 Nov 15;57(4):1010-8.

PMID:
14575832
8.
9.

Does prophylactic treatment with proteolytic enzymes reduce acute toxicity of adjuvant pelvic irradiation? Results of a double-blind randomized trial.

Martin T, Uhder K, Kurek R, Roeddiger S, Schneider L, Vogt HG, Heyd R, Zamboglou N.

Radiother Oncol. 2002 Oct;65(1):17-22.

PMID:
12413670
11.
12.

Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy.

Atlan D, Touboul E, Deniaud-Alexandre E, Lefranc JP, Antoine JM, Jannet D, Lhuillier P, Uzan M, Huart J, Genestie C, Antoine M, Jamali M, Ganansia V, Milliez J, Uzan S, Blondon J.

Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):780-93.

PMID:
12377330
13.

Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.

Chung YL, Jian JJ, Cheng SH, Hsieh CI, Tan TD, Chang HJ, Hung CF, Horng CF, Soong T, Tsou MH.

Gynecol Oncol. 2005 Apr;97(1):126-35.

PMID:
15790448
14.

[Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].

Lerouge D, Touboul E, Lefranc JP, Uzan S, Jannet D, Moureau-Zabotto L, Genestie C, Antoine M, Jamali M.

Cancer Radiother. 2004 Jun;8(3):168-77. French.

PMID:
15217584
15.
16.

[Prospective double-blind study of prophylaxis of radioxerostomia with Coumarin/Troxerutine in patients with head and neck cancer].

Grötz KA, Henneicke-von Zepelin HH, Kohnen R, al-Nawas B, Bockisch A, Kutzner J, Wüstenberg P, Naser-Hijazi B, Belz GG, Wagner W.

Strahlenther Onkol. 1999 Aug;175(8):397-403; discussion 404. German.

PMID:
10481772
17.

Amifostine reduces radiochemotherapy-induced toxicities in patients with locally advanced non-small cell lung cancer.

Antonadou D, Petridis A, Synodinou M, Throuvalas N, Bolanos N, Veslemes M, Sagriotis A.

Semin Oncol. 2003 Dec;30(6 Suppl 18):2-9.

PMID:
14727235
19.

High versus low dose rate intracavitary irradiation for adenocarcinoma of the uterine cervix.

Kim WC, Kim GE, Suh CO, Loh JJ.

Jpn J Clin Oncol. 2001 Sep;31(9):432-7.

PMID:
11689597
20.

Effect of amifostine on toxicities associated with radiochemotherapy in patients with locally advanced non-small-cell lung cancer.

Antonadou D, Throuvalas N, Petridis A, Bolanos N, Sagriotis A, Synodinou M.

Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):402-8.

PMID:
12957251

Supplemental Content

Support Center